Can sildenafil (Viagra) be taken together with dofetilide?

No, sildenafil and dofetilide should NOT be taken together

The combination of sildenafil (Viagra) and dofetilide is contraindicated due to the risk of life-threatening QT interval prolongation and torsades de pointes.

Critical Drug Interaction

Dofetilide is a class III antiarrhythmic medication that prolongs the QT interval as its primary mechanism of action 1. This QT prolongation carries an inherent risk of torsades de pointes, a potentially fatal ventricular arrhythmia. The drug requires mandatory inpatient monitoring during initiation specifically because of this risk 2, 3.

Sildenafil, as a PDE5 inhibitor, can also affect cardiac repolarization and has vasodilatory properties 4. When combined with medications that prolong the QT interval, sildenafil may potentiate this effect, creating an additive risk for dangerous arrhythmias.

Why This Combination Is Dangerous

QT prolongation is dose-dependent and cumulative. Studies show that 15% of patients discontinue dofetilide during initiation due to excessive QT prolongation alone 5. Adding sildenafil to this equation increases the risk of:

• Torsades de pointes: A polymorphic ventricular tachycardia that can degenerate into ventricular fibrillation and sudden cardiac death
• Syncopal episodes: From both arrhythmia and hypotension
• Hemodynamic instability: Particularly problematic in patients already on dofetilide, who often have structural heart disease

Clinical Context

Patients prescribed dofetilide typically have:

• Atrial fibrillation requiring rhythm control 1, 6
• Often concurrent structural heart disease 5, 7
• Reduced left ventricular ejection fraction in many cases 2

These patients are already at elevated cardiovascular risk. The FDA label for sildenafil explicitly warns about caution in patients with cardiovascular disease and those taking medications that may interact 4.

Common Pitfall to Avoid

Do not assume that because both drugs are commonly prescribed, they can be safely combined. Dofetilide has very specific contraindications related to QT prolongation, and any medication that can further prolong the QT interval or affect cardiac repolarization should be avoided. The fact that dofetilide requires mandatory inpatient ECG monitoring for the first five doses 2, 3 underscores how narrow its therapeutic window is.

What to Do Instead

For patients on dofetilide who develop erectile dysfunction:

1. Consider alternative ED treatments that do not affect cardiac repolarization:

   • Vacuum erection devices 8, 9
   • Intracavernosal injections (alprostadil, papaverine, phentolamine) 8, 10
   • Intraurethral alprostadil suppositories 8

2. Consult cardiology before prescribing any PDE5 inhibitor to assess:

   • Current QTc interval on dofetilide
   • Overall arrhythmia burden
   • Whether dofetilide can be safely discontinued or switched to an alternative antiarrhythmic

3. If a PDE5 inhibitor is absolutely necessary, the patient's cardiologist must first determine if dofetilide can be discontinued or replaced with an antiarrhythmic that does not prolong the QT interval (such as flecainide in patients without structural heart disease, or catheter ablation) 1, 6.

The risk of sudden cardiac death from this combination far outweighs any potential benefit for erectile dysfunction treatment.